Travere Therapeutics has set its…
Travere Therapeutics has set its sights on Everest Medicines’ therapy [...]
For patients with a rare cancer…
For patients with a rare cancer that arises in the [...]
Rallybio has steered its way to a…
Rallybio has steered its way to a new reverse merger, [...]
Days after its lead clinical-stage…
Days after its lead clinical-stage asset suffered a setback, Agios [...]
Kelonia Therapeutics has shared…
Kelonia Therapeutics has shared the largest slice of data yet [...]
In the race to forge the next…
In the race to forge the next Keytruda from PD-(L)1xVEGF [...]
This year’s meeting of the…
This year’s meeting of the American Society of Clinical Oncology [...]
The German biotech shared updated…
The German biotech shared updated data from a phase 1 [...]
Nine years after wowing the…
Nine years after wowing the audience at the American Society [...]
AstraZeneca has shared data it…
AstraZeneca has shared data it believes can rescue anselamimab from [...]